Measles, Mumps and Rubella

Key points
- As late as the 1950s, and before a vaccine was developed, parents were encouraged to expose their children to diseases like measles, mumps, and chicken pox to develop immunity.
- For hundreds of years, measles was so ubiquitous it was thought to be a natural episode of childhood.
- Mumps, a viral disease, used to be common in childhood.
- Rubella (German measles) is considered a mild childhood disease characterized by a pink rash.
As late as the 1950s, and before a vaccine was developed, parents were encouraged to expose their children to diseases like measles, mumps, and chicken pox to develop immunity. With the marketing of an effective vaccine to protect people from these diseases, such thinking was rendered moot. Building on the momentum of success achieved with the oral polio vaccine, a number of live attenuated vaccines were being developed. The most significant of these at the time was the measles-mumps-rubella (MMR) vaccine.
For hundreds of years, measles was so ubiquitous it was thought to be a natural episode of childhood. It was not until the 14th century that the word "measles" was used, stemming from the word "miser," which was used to refer to the wretchedness of lepers.[18] Before the development of an effective vaccine, measles was one of the most common childhood diseases in America. Characterized by fever and a rash, measles is a serious disease that is highly contagious and can lead to death; but recovery confers a lifelong immunity. Interestingly, women who have been vaccinated but who never had the disease do not have natural maternal measles antibodies to pass on to their babies, which mean that most babies born in America are vulnerable to getting this disease.
Mumps, a viral disease, used to be common in childhood. Discovery of the mumps virus in 1934 helped researchers gain a better understanding of the symptoms and how this disease is transmitted. Characterized by fever, headache, and inflammation of the salivary glands (making the cheeks swell, producing the signature sign of the disease), this disease rarely leads to death. Recovery confers lifelong immunity.
Rubella (German measles) is considered a mild childhood disease characterized by a pink rash. While similar to measles, the rubella virus is comparatively benign and less infectious. Recovery usually confers lifelong immunity although repeat cases can occur, albeit rarely. Should a pregnant woman get rubella in the first trimester of pregnancy, there is a greater chance of giving birth to a baby with birth defects.
A measles vaccine was licensed in 1963, and a rubella vaccine was licensed in 1969, and the trivalent MMR vaccine was licensed in 1971. Protection is estimated to last for up to 11 years. Despite the availability of the vaccine, however, around 1 million children, predominantly in resource-poor countries, die every year from measles. Even in the United States, outbreaks occur. For example, a measles outbreak in the 1980s and early 1990s showed that there were a significant number of vaccine failures in older children, teenagers, and adults, especially among those who had been vaccinated before 15 months of age. As such, the government recommended that a second MMR booster be given either before a child enters kindergarten or before entering junior high school. Almost all who get the vaccine have no serious adverse reactions from it.
{embed="ref/stat-menu-disease-prevention-vaccination"}
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsMarijuana May Stop The Spread Of HIV, Study Finds
Marijuana has long been used to effectively treat symptoms associated with HIV, such as chronic pain and weight loss. But a growing body of research suggests the plant may be able to stop the spread of the disease…
20 November 2015
NewsScottish university scientist behind successful rapid-detection Ebola test
A rapid-detection Ebola test developed by international scientists including a University of Stirling, Scotland virologist has been deployed following a highly effective pilot project. Dr Manfred Weidmann, from the…
7 November 2015
NewsStudy shows effectiveness of switching antiretroviral therapy for HIV-infected children
A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one…


